Executives Buy Xencor Shares, Signaling Confidence in Near‑Term Growth
Executives buy 10,302 Xencor shares & 20,604 options, showing strong confidence in its antibody pipeline and upcoming regulatory milestones.
3 minutes to read
XENCOR INC
Insider Sales at Xencor Inc. Show Routine Liquidity, Not a Bear Signal
Insider sales at Xencor Inc. were routine, compensation‑driven trades that did not signal a decline in fundamentals—investors see the company’s biotech prospects as solid.
3 minutes to read
Insider Buys at Xencor Signal Confidence Despite Volatile Market & Negative P/E
Insider trades at Xencor signal confidence amid volatility; executives’ buying, buzz, and a recent earnings beat suggest potential upside for biotech investors.
4 minutes to read